Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S17 pseudogene 1 (MRPS17P1) is a processed pseudogene corresponding to the functional mitochondrial ribosomal protein S17 gene (MRPS17)[1][4]. MRPS17P1 does not encode a functional protein and is not involved in mitochondrial translation or other defined cellular processes. Like many pseudogenes, it is likely transcriptionally inactive in most contexts and lacks therapeutic or diagnostic utility. Pseudogenes generally arise through gene duplication or retrotransposition, and some may regulate their parent genes by acting as competing endogenous RNAs, but no such role has been described for MRPS17P1 specifically[2]. If you require structured data for the functional mitochondrial ribosomal protein S17 (MRPS17), refer to gene and protein databases rather than the pseudogene MRPS17P1[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S17 pseudogene 1 (MRPS17P1).